Initiator Pharma appoints Annette Säfholm as chief operating business officer

Reuters2026/09/14 06:34

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Initiator Pharma appointed Annette Säfholm as chief operating business officer, adding her to the management team.
She will support the CEO on business development, partnering, strategic discussions, operational execution.
Säfholm previously served as CEO of Gedea Biotech, leading it through clinical development, EU MDR approval, commercial readiness.
The appointment comes as the company advances a Phase IIa pudafensine study in vulvodynia, targeting topline data by end-2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Initiator Pharma A/S published the original content used to generate this news brief on September 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Recently, Meta launched its personal AI agent product, Muse AI, marking the transition of consumer artificial intelligence from Q&A-based chatbots to an era of intelligent agents capable of independently completing real-world tasks. Goldman Sachs released a research report maintaining a “Buy” rating on Meta.

智通财经•2026/09/14 07:16